AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Jglime M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Jeevan Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Jglime M 2mg/500mg Tablet SR

Diabexe Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabexe Duo should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended as directed by your doctor.

Primary Ingredients of Jglime M 2mg/500mg Tablet SR

There is no text provided to rephrase.

Uses of Jglime M 2mg/500mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Jglime M 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Jglime M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Jglime M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Jglime M 2mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Jglime M 2mg/500mg Extended-Release tablets should be taken with a meal.

How Jglime M 2mg/500mg Tablet SR works:

Jglime M 2mg/500mg Extended-Release Tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Jglime M 2mg/500mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Jglime M 2mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Jglime M tablets (2mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Jglime M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification under medical supervision. Jglime M 2mg/500mg SR tablets are contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment with this medication.

LiverLiverCAUTION

Individuals with liver impairment should use Jglime M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiating treatment with a low dose of Jglime M 2mg/500mg SR tablets is typical; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Jglime M 2mg/500mg Tablet SR :

Should you forget a dose of Jglime M 2mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Jglime M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Jglime M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Jglime M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience any of these, discontinue Jglime M 2mg/500mg Tablet SR and seek immediate medical attention.
Jglime M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Jglime M 2mg/500mg SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Jglime M 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Jglime M 2mg/500mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Jglime M 2mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Jglime M 2mg/500mg Tablet...
53
MRP 65
18% off